News

Perceptive Informatics has launched product convergence between its DataLabs EDC solution and ClinPhone Randomisation and Trial Supply Management (RTSM) technologies. New functionality in the DataLabs EDC solution has

Cumberland Pharmaceuticals (Cumberland) has entered into an exclusive agreement with DB Pharm Korea for the commercialisation of Caldolor (ibuprofen) injection in South Korea. Designed to treat pain and

Atrium Medical has enrolled first patient in the Infuse AMI trial. Infuse AMI is a multi-center, multi-national, prospective, randomised, single blind trial, examining how patients with heart attacks

OvumOptics has introduced Ovu-Trac Ovulation Predictor Kit, which helps women increase their chances of conception, naturally, without medical intervention. The company said that Ovu-Trac kit uses saliva sampling

Hemodynamic has completed its initial Phase 2 clinical study of its compound (HTI-101), a patented low-dose small-molecule investigational therapy intended for patients with treatment-resistant hypertension. The 12-week double-blind

Perrigo has filed an Abbreviated New Drug Application (ANDA) for clobetasol propionate topical spray, 0.05%, a generic form of Clobex Spray. Clobex (clobetasol propionate) spray is indicated for

Applied Biosystems, part of LifeTechnologies has entered into the flow cytometry instrumentation market with the Attune Acoustic Focusing Cytometer, a first cytometry system designed to use sound waves

Dynavax’s GMP manufacturing facility in Dusseldorf, Germany has been approved for the commercial production of hepatitis B surface antigen, a key component of Heplisav, an investigational adult hepatitis

Pacific Beach BioSciences has granted non-exclusive rights to a pharmaceutical company for the use of one of its anti-fungal compounds required for the manufacturing of a clinical stage